About LIINC

Study Information

The Long-term Impact of Infection with Novel Coronavirus (LIINC) study is a collaboration of University of California researchers looking for adult volunteers who have had a confirmed or suspected COVID-19 infection. Our team is working to understand the changes that happen after recovery from the virus.

LIINC is a team effort that connects researchers across UCSF and the United States with the goal of understanding the immune response to the virus and how it affects a person's body during recovery.

Study Participation

What to Expect?

If you are interested in participating in the study, you will first undergo a Phone Screen with a member of our study team. They will ask you information about your medical history, COVID-19 infection(s), and if you are experiencing any lingering symptoms.

If you are eligible, you will be invited to a Baseline Visit at Zuckerberg San Francisco General Hospital. At that visit, you will meet with a member of the study team, review the consent and sign it if you wish to participate. If you do choose to participate, the Baseline Visit will include a detailed questionnaire about your health and COVID-19 history as well as a blood draw.

After the first visit, you will be asked to be seen about every 6 months. Each visit will include a brief questionnaire and a blood test.

Eligibility Criteria

Am I Eligible to Participate in the Study?

To be able to participate in the study, you must meet the following criteria:

  1. You are at least 18 years old.
  2. You have have had at least one confirmed SARS-CoV-2 infection or a suspected infection according to the World Health Organization criteria
  3. You are able to attend in-person study visits 2-3 times per year at our research center at the Zuckerberg San Francisco General Hospital campus.

Will I Be Paid?

You will be paid $50 for completing the Baseline Visit and $25 for completing each follow-up visit.

FAQ

Frequently Asked Questions

The Long-term Impact of Infection with Novel Coronavirus (LIINC) study is a collaborative research effort led by the University of California. It aims to understand the long-term effects of COVID-19 on immunity and different organ systems by studying recovered patients.

Adults (18 years+) who have tested positive for COVID-19 (SARS-CoV-2) and are able to attend in-person visits 3-4 times per year at our research center on the San Francisco General Hospital campus are eligible to participate.

Interested individuals will undergo a phone screen, and if eligible, will attend a screening visit to sign consent forms and participate in the Baseline Visit, which includes a detailed questionnaire, a blood draw, and saliva collection. Follow-up visits occur every 4 months and involve a brief questionnaire and a blood test.

 

Participants will receive $50 for completing the Baseline Visit and $25 for each follow-up visit.

After the initial Baseline Visit, participants are expected to visit the research center every 4 months for follow-up assessments.

During each follow-up visit, participants will complete a brief questionnaire and undergo a blood test to help researchers assess the ongoing effects of COVID-19 on their health.

The study is planned to continue for two years, during which participants may be asked to attend several follow-up visits to track changes in their health post-recovery.